On 21 September 2023, IFPMA submitted a statement at the UN High-Level Meeting on Universal Health Coverage in New York.
Read moreAhead of the 78th session of the United Nations General Assembly (UNGA78), IFPMA Director General, Thomas Cueni underscores the need for pandemic preparedness plans to support innovation and equity. Global leaders must ensure science and innovation can again deliver at record speed and scale, while supporting voluntary partnerships and enabling scientists to have unhindered access...
Read moreOn 20 September 2023, IFPMA submitted a statement at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response in New York.
Read moreDuring the UN General Assembly this month and going forward, progress towards delivering Universal Health Coverage (UHC) will be front of stage. Achieving UHC was a commitment made as part of the 2030 Sustainable Development Goals (SDGs) when adopted in 2015 – so this year marks the half-way point in the journey towards 2030. If...
Read moreOur industry knows better than most that failure is an intrinsic and important part of scientific research and development. Even when the development of a potential new medicine isn’t successful, it can still play a crucial role in understanding a disease and provide important data for the next step of the journey. The journey toward...
Read moreAs the drive toward Universal Health Coverage (UHC) and the 2030 Sustainable Development Goals (SDGs) intensifies, so too does the urgency to respond to the mounting burden of NCDs, especially in low- and middle-income countries (LMICs) where their impact is most acute. Of the 41 million NCD-related deaths per year globally, 77% are in LMICs....
Read moreIn the spirit of the Global Week for Action on NCDs, this report reiterates the long-standing commitment of the innovative pharmaceutical industry to bring innovative solutions, bridge the NCDs care gap, and accelerate Universal Health Coverage (UHC) and the 2030 Sustainable Development Goals (SDGs).
Read moreAhead of discussions at the United Nations General Assembly (UNGA78), the trade association representing the innovative pharmaceutical industry, the IFPMA, has warned that current pandemic preparedness plans should not undermine what worked well in response to COVID-19 and must support both “innovation and equity.”
Read moreThe International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and Speak Up Africa announced 15 candidates shortlisted for the 2nd edition of the Africa Young Innovators for Health Award.
Read moreAs leaders and health experts from across the world gather in New York for the UN General Assembly, they are considering three issues that are critical to the future of global health and global health security. As world leaders discuss political declarations on ending tuberculosis (TB), delivering universal health coverage (UHC) and strengthening pandemic prevention, preparedness...
Read moreInnovation often comes in waves, set in motion by science. Such was the case when a cure was found for hepatitis C virus (HCV). It was followed by others in quick succession, giving us multiple tools to successfully tackle the disease. The story of HCV shows us what a thriving innovation ecosystem can achieve –...
Read more